Version history

{
  "session_id": "pan_e387991a",
  "round_number": 1,
  "agent_persona": "persona-synthesizer",
  "agent_backend": "pantheon-stub",
  "action": "respond",
  "content": "\n\n{\"response\": {\n  \"topic\": \"Role of microglial TREM2 in Alzheimer disease pathology\",\n  \"session_id\": \"pan_e387991a\",\n  \"distinctive_perspective\": \"TREM2 functions as a metabolic checkpoint for microglial fitness rather than a simple clearance engine, and its therapeutic window depends on disease stage timing.\",\n  \"key_claims\": [\n    {\n      \"claim\": \"TREM2 R47H/Haploinsufficiency variants confer 2-4x increased AD risk, establishing TREM2 as one of the strongest microglial genetic risk factors identified to date\",\n      \"mechanism\": \"Impaired sensing of lipid ligands and myelin debris leads to microglial metabolic dysfunction\"\n    },\n    {\n      \"claim\": \"TREM2 drives the disease-associated microglia (DAM) transcriptional program, enabling metabolic adaptation to neurodegeneration\",\n      \"mechanism\": \"Without TREM2 signaling, microglia cannot transition from homeostatic to protective DAM state, leaving them metabolically vulnerable\"\n    },\n    {\n      \"claim\": \"TREM2 deficiency paradoxically increases plaque numbers but decreases plaque compaction, worsening neuritic dystrophy\",\n      \"mechanism\": \"Microglia fail to physically wall off amyloid deposits, allowing toxic diffusion into neuropil\"\n    },\n    {\n      \"claim\": \"The therapeutic challenge is temporal: TREM2 agonism may help early (promoting clearance) but risks exacerbating inflammation if applied late-stage\",\n      \"mechanism\": \"Chronically activated microglia can shift from protective to destructive phenotypes depending on context\"\n    }\n  ],\n  \"controversy_flag\": \"Current debate exists whether TREM2 agonism will primarily benefit pre-symptomatic at-risk individuals or those with established pathology; clinical trial targeting (AL002) is enrolling early-stage patients\",\n  \"distinction_from_peers\": \"Emphasizes TREM2 as metabolic regulator rather than just phagocytic enhancer, and highlights the critical timing variable often underdiscussed in broad reviews\"\n}}",
  "tokens_used": "0",
  "persona_id": "persona-synthesizer"
}